http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2012132630-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-25 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-22 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-14 |
| filingDate | 2010-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2012132630-A |
| titleOfInvention | CULTURAL ENVIRONMENT FOR SCREENING OR ENRICHMENT OF METICILLIN-RESISTANT S.aureus |
| abstract | 1. Culture medium for screening or enriching methicillin-resistant Staphylococcus aureus (MRSA), which contains a combination of at least two cephalosporins. The culture medium according to claim 1, which further comprises a chromogenic agent. The culture medium according to claim 2, wherein the chromogenic agent is 6-chloro-3-indoxyl phosphate. The culture medium according to claim 1, which is an agar culture medium. The culture medium according to claim 1, which is a broth. The culture medium according to claim 1, which contains two cephalosporins. The culture medium according to claim 1, which contains three cephalosporins. The culture medium of claim 1, wherein said cephalosporins are selected from the group consisting of cefotetan (CTT), ceftriaxone (CRO), cefuroxime (CXM), cefsulodine (CFS), ceftibutene (STV), cefepime (FEP), cefoperazone (CFP) cefpodoxime (CPD), cefoxitin (FOX), phloxef, cefmetazole (CMT), moxalactam (MOX) and ceftiofur (XLN) .9. The culture medium of claim 8, which contains a combination of cephalosporins selected from the group consisting of: cefotetan and ceftriaxone; cefotetan and cefoxitin; cefotodoxim and cefpodoxime; cefpodoxime and cefsulodin; cefuroxime and cefsulfodinodin; cefulfulfodin; ; cefsulodin and cefepime; moxalactam and cefoxitin; moxalactam and cefpodoxime; cefotetan and ceftiofur; cefpodoxime and ceftriaxone; cefoperazone and ceftiofur; cefoperazone and cefsulodine; ceftisone she and cefuroxime; cefotetane and ceftibutene; ceftriaxone and ceftibutene; and ceftriaxone and cefepime. 10. The culture medium according to claim 1, where each cephalosporin is present in a concentrate |
| priorityDate | 2009-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 49.